A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus.

The article presents a review paper titled "A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus." Topics discussed include chart depicting patient demographics and baseline characteristics, chart depicting change from baseline in exploratory values including homeostatic model assessment measure, and adverse events like diarrhea, colon cancer, and depression occurring in greater than 2 percent patients.